Dermatologicals in Japan

October 2022
Select Country Report
USD 990
Request More Information

Delivery:

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

This report comes in PDF with additional info in Excel included.

Overview:

Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Japan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Medicated Skin Care industry in Japan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Medicated Skin Care in Japan report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Medicated Skin Care in Japan?
  • Which are the leading brands in Medicated Skin Care in Japan?
  • How are products distributed in Medicated Skin Care in Japan?
  • How has the regulatory and operating environment for Medicated Skin Care changed in Japan?
  • How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Medicated Skin Care
  • How significant are wider health concerns and consumer awareness in determining sales?
  • Where is future growth expected to be most dynamic?
Download Table of Contents

Dermatologicals in Japan - Category analysis

KEY DATA FINDINGS

Growth of dermatologicals remains stable in 2022, but performances vary across categories
Reduced activity and prolonged telecommuting maintain sales of haemorrhoid treatments
COVID-19 increases the time spent at home, and the demand for self-care for scalp problems and thinning hair increases
Dermatologicals will remain steady after 2023
New lifestyles and impact of COVID-19 to maintain sales of haemorrhoid treatments in the early forecast period
Hair loss treatments expected to grow, but fierce competition will require brands to consider pricing and distribution strategies
Table 1 Sales of Dermatologicals by Category: Value 2017-2022
Table 2 Sales of Dermatologicals by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Dermatologicals: % Value 2018-2022
Table 4 LBN Brand Shares of Dermatologicals: % Value 2019-2022
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
Table 6 Forecast Sales of Dermatologicals by Category: Value 2022-2027
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027

Consumer Health in Japan - Industry Overview

Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 9 Life Expectancy at Birth 2017-2022
Table 10 Sales of Consumer Health by Category: Value 2017-2022
Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format: % Value 2017-2022
Table 16 Distribution of Consumer Health by Format and Category: % Value 2022
Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022

DISCLAIMER

DEFINITIONS

Summary 2 Research Sources
The following categories and subcategories are included:

Medicated Skin Care

  • Medicated Shampoos
  • Topical Antifungals
  • Vaginal Antifungals
  • Hair Loss Treatments
  • Nappy (Diaper) Rash Treatments
  • Antiparasitics/Lice (Head and Body) Treatments
  • Antipruritics
  • Cold Sore Treatments
  • Haemorrhoid Treatments
  • Paediatric Dermatologicals
  • Topical Allergy Remedies/Antihistamines
  • Topical Germicidals/Antiseptics

Medicated Skin Care

Includes topical standard and herbal/traditional medicated products used to alleviate symptoms or treat skin or hair ailments. Exclude any systemic (oral) options to treat skin conditions or diseases.

See All of Our Definitions
Share:

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Medicated Skin Care research and analysis database.

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!

© 2023 Euromonitor is privately owned & trademarked. VAT No. GB: 239-2559-40 Registered in England No. 1040587
;